AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation

被引:190
作者
Cheung, Win D. [1 ]
Hart, Gerald W. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
关键词
D O I
10.1074/jbc.M801222200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have demonstrated previously that a wide array of stress signals induces O-GlcNAc transferase ( OGT) expression and increases O-GlcNAcylation of many intracellular proteins, a response that is critical for cell survival. Here, we describe a mechanism by which glucose deprivation induces OGT expression and activity in Neuro-2a neuroblastoma cells. Glucose deprivation increases OGT mRNA and protein expression in an AMP-activated protein kinase-dependent manner, whereas OGT enzymatic activity is regulated in a p38 MAPK-dependent manner. OGT is not phosphorylated by p38, but rather it interacts directly with p38 through its C terminus; this interaction increases with p38 activation during glucose deprivation. Surprisingly, the catalytic activity of OGT, as measured toward peptide substrates, is not altered by glucose deprivation. Instead, p38 regulates OGT activity within the cell by recruiting it to specific targets, including neurofilament H. Neurofilament H is O-GlcNAcylated during glucose deprivation in a p38-dependent manner. Interestingly, neurofilament H solubility is increased by glucose deprivation in an O-GlcNAc-dependent manner, suggesting that O-GlcNAcylation of neurofilament H regulates its disassembly from filaments. Not only do these data help to reveal how OGT is regulated by stress, but these findings also describe a possible mechanism by which defective brain glucose metabolism, as found in aging and ischemia, may directly affect axonal structure.
引用
收藏
页码:13009 / 13020
页数:12
相关论文
共 73 条
[1]   p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis [J].
Ackerley, S ;
Grierson, AJ ;
Banner, S ;
Perkinton, MS ;
Brownlees, J ;
Byers, HL ;
Ward, M ;
Thornhill, P ;
Hussain, K ;
Waby, JS ;
Anderton, BH ;
Cooper, JD ;
Dingwall, C ;
Leigh, PN ;
Shaw, CE ;
Miller, CCJ .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 26 (02) :354-364
[2]   O-GlcNAc modification of nucleocytoplasmic proteins and diabetes [J].
Akimoto Y. ;
Hart G.W. ;
Hirano H. ;
Kawakami H. .
Medical Molecular Morphology, 2005, 38 (2) :84-91
[3]   The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine [J].
Arnold, CS ;
Johnson, GVW ;
Cole, RN ;
Dong, DLY ;
Lee, M ;
Hart, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28741-28744
[4]  
Barone FC, 2001, J PHARMACOL EXP THER, V296, P312
[5]   Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+
[6]   CHARACTERIZATION OF HUMAN N-ACETYL-BETA-HEXOSAMINIDASE-C [J].
BRAIDMAN, I ;
CARROLL, M ;
DANCE, N ;
ROBINSON, D ;
POENARU, L ;
WEBER, A ;
DREYFUS, JC ;
OVERDIJK, B ;
HOOGHWINKEL, GJ .
FEBS LETTERS, 1974, 41 (02) :181-184
[7]   Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences [J].
Bramlett, HM ;
Dietrich, WD .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (02) :133-150
[8]  
CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3
[9]   Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β [J].
Cheng, XG ;
Cole, RN ;
Zaia, J ;
Hart, GW .
BIOCHEMISTRY, 2000, 39 (38) :11609-11620
[10]   Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II [J].
Comer, FI ;
Hart, GW .
BIOCHEMISTRY, 2001, 40 (26) :7845-7852